Government to Launch Cashless Treatment Scheme for Road Accident Victims in India

Prime Minister Narendra Modi set to introduce a new cashless medical treatment scheme aimed at providing financial relief to road accident victims across India.  

This initiative, announced by Road, Transport, and Highways Minister Nitin Gadkari, is set to offer significant support to those affected by road mishaps. 

Details of the Cashless Treatment Scheme 

The scheme provides road accident victims with cashless medical treatment coverage of up to ₹1,50,000 for a minimum duration of 7 days.  

This initiative is designed to ensure that victims receive timely and adequate medical care without the immediate burden of financial constraints. 

In addition to the treatment coverage, the scheme also recognises the efforts of Good Samaritans who assist accident victims in reaching hospitals. These individuals, termed as Rahveers, will be awarded ₹25,000 for their noble actions. 

Successful Pilot Projects 

The scheme has already undergone successful pilot testing in several states and union territories, including Uttar Pradesh, Haryana, Punjab, and Chandigarh.  

These trials have demonstrated the scheme's potential to provide critical support to accident victims and encourage public participation in emergency response. 

Role of Good Samaritans 

The initiative places a strong emphasis on the role of Good Samaritans in saving lives. By offering financial rewards, the government aims to motivate more individuals to assist accident victims promptly, thereby improving survival rates and recovery outcomes. 

Read More: Government Plans to Mandate Sound to E-rickshaws and E-karts to Protect Pedestrians! 

Conclusion 

The launch of the cashless treatment scheme marks a significant step in enhancing road safety and providing immediate medical assistance to accident victims in India. By offering financial support and recognising the efforts of Good Samaritans, the government aims to foster a more responsive and caring society. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.